AxeroVision, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
- Website
- https://www.axerovision.com/
Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction
Phase 2
Completed
- Conditions
- Posterior BlepharitisMeibomian Gland Dysfunction
- Interventions
- Drug: AXR-270 Low DoseDrug: AXR-270 High DoseDrug: AXR-270 Vehicle
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- AxeroVision, Inc.
- Target Recruit Count
- 129
- Registration Number
- NCT04469998
- Locations
- 🇺🇸
AxeroVision, Inc., Carlsbad, California, United States
A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- AxeroVision, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT03598699
- Locations
- 🇺🇸
Total Eye Care, P.A., Memphis, Tennessee, United States
🇺🇸Andover Eye Associates, Raynham, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath